Update from Merck About Sinemet

Rate this post

March 2011 Monthly Message

  • April is Parkinson’s Recognition Month
  • FRYING PAN CEO, Amy Comstock Rick, Testifies on Capitol Hill on behalf of Small Company
  • Update from Merck Regarding Sinemet
  • 2011 Frying Pan Online Forum: Making Our Voices Listened To in Congress
  • National Neurological Conditions Monitoring System Act Will Develop Parkinson’s as well as Several Sclerosis Condition Pc Registries
  • CONSERVE THE DATE– 2011 Morris K. Udall Honors Supper
  • Medtronic Global Heroes Seek Marathon Runners
  • Parkinson’s in the Media homepage

The Parkinson’s Activity Network (FRYING PAN) recently obtained a letter from Dr. Sethu Reddy, Vice President of U.S. Medical Matters for Merck & Co., Inc., the maker of Sinemet, introducing they had actually successfully collaborated with the Fda to acquire approval of the brand-new supply sources of Sinemet to prevent scarcities and also supply problems.

To maintain the Parkinson’s neighborhood fully notified of this problem, PAN has consisted of details on the new-look Sinemet and Sinemet CR pills, in addition to even more comprehensive info about the medicine, all sent out by Merck. If you have any inquiries regarding your personal healthcare after reading this details, please talk to your doctor or pharmacist.